Jacques Rouanet

521 total citations
24 papers, 227 citations indexed

About

Jacques Rouanet is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Jacques Rouanet has authored 24 papers receiving a total of 227 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Molecular Biology. Recurrent topics in Jacques Rouanet's work include Cancer Immunotherapy and Biomarkers (6 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Melanoma and MAPK Pathways (4 papers). Jacques Rouanet is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Radiopharmaceutical Chemistry and Applications (5 papers) and Melanoma and MAPK Pathways (4 papers). Jacques Rouanet collaborates with scholars based in France, United States and Russia. Jacques Rouanet's co-authors include Françoise Degoul, Philippe Auzeloux, M. D’Incan, Mercédès Quintana, Sophie Besse, F. Cachin, Yves Cazals, Juliette Vergnaud, Fabrice Kwiatkowski and Bruno Pereira and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Pharmacology & Therapeutics.

In The Last Decade

Jacques Rouanet

22 papers receiving 222 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacques Rouanet France 9 93 72 40 39 30 24 227
Meng‐Fang Wu China 9 26 0.3× 16 0.2× 72 1.8× 27 0.7× 49 1.6× 13 278
M. I. Melhorn United States 7 72 0.8× 45 0.6× 72 1.8× 27 0.7× 11 0.4× 9 219
Sara Cecco Italy 8 120 1.3× 16 0.2× 99 2.5× 45 1.2× 48 1.6× 13 351
Xinwei Yang China 9 32 0.3× 14 0.2× 94 2.4× 17 0.4× 19 0.6× 29 268
Yury Saenko Russia 7 29 0.3× 104 1.4× 120 3.0× 10 0.3× 108 3.6× 33 270
Lingling Liang China 10 20 0.2× 51 0.7× 118 3.0× 21 0.5× 26 0.9× 41 294
Young-Jae Kim South Korea 9 16 0.2× 33 0.5× 88 2.2× 15 0.4× 40 1.3× 29 299
Lara Stepan United States 6 167 1.8× 63 0.9× 95 2.4× 50 1.3× 35 1.2× 7 318
Ming‐Hao Dong China 13 134 1.4× 12 0.2× 125 3.1× 110 2.8× 12 0.4× 28 421

Countries citing papers authored by Jacques Rouanet

Since Specialization
Citations

This map shows the geographic impact of Jacques Rouanet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques Rouanet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques Rouanet more than expected).

Fields of papers citing papers by Jacques Rouanet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques Rouanet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques Rouanet. The network helps show where Jacques Rouanet may publish in the future.

Co-authorship network of co-authors of Jacques Rouanet

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques Rouanet. A scholar is included among the top collaborators of Jacques Rouanet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques Rouanet. Jacques Rouanet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thivat, Émilie, Sylvain Mathieu, Philippe Auzeloux, et al.. (2025). [99mTc]Tc-NTP 15 − 5, a new proteoglycan tracer for functional imaging of joint cartilage: phase I (CARSPECT). EJNMMI Research. 15(1). 123–123. 1 indexed citations
2.
Nardin, Charlée, Célèste Lebbé, Cécile Pagès, et al.. (2024). Neoadjuvant immune checkpoint inhibitors for patients with resectable stage III/IV melanoma: A nationwide real-life study in France (NEOMEL).. Journal of Clinical Oncology. 42(16_suppl). 9578–9578.
3.
Guièze, Romain, et al.. (2024). Pyoderma gangrenosum-like neutrophilic dermatosis as an adverse effect of menin-KMT2A inhibitor therapy for acute myeloid leukaemia. Annals of Hematology. 103(12). 5985–5988. 1 indexed citations
4.
5.
Battistella, Maxime, Lin‐Pierre Zhao, Gábor Dobos, et al.. (2023). CD38 Targeting in Aggressive, Treatment-Refractory Cutaneous T-Cell Lymphomas. Journal of Investigative Dermatology. 143(7). 1329–1332.e3. 6 indexed citations
6.
Balayssac, David, Bruno Pereira, Carine Chaleteix, et al.. (2023). Satisfaction of Cancer Patients Treated with Oral Anticancer Medications regarding Dispensing by Community Pharmacists: A Cross-Sectional Study. European Journal of Cancer Care. 2023. 1–9.
7.
Magnin, Benoît, et al.. (2022). The Role of Surgery After Remission of Nonsystemic Extensive Periorbital Basal Cell Carcinoma Treated by Vismodegib: A Systematic Review. Dermatologic Surgery. 48(9). 905–911. 2 indexed citations
8.
Thivat, Émilie, Sylvain Mathieu, Philippe Auzeloux, et al.. (2022). Assessment of 99mTc-NTP 15-5 uptake on cartilage, a new proteoglycan tracer: Study protocol for a phase I trial (CARSPECT). Frontiers in Medicine. 9. 993151–993151. 1 indexed citations
9.
Rouanet, Jacques, Constance Hordonneau, Bruno Pereira, et al.. (2022). Metastatic melanoma treated by immunotherapy: discovering prognostic markers from radiomics analysis of pretreatment CT with feature selection and classification. International Journal of Computer Assisted Radiology and Surgery. 17(10). 1867–1877. 6 indexed citations
10.
Rouanet, Jacques, et al.. (2022). Real-life Use of Bexarotene for T-cell Cutaneous Lymphoma Management: Efficacy and Tolerance with Low Doses. Acta Dermato Venereologica. 102. adv00746–adv00746. 2 indexed citations
11.
Thivat, Émilie, Jacques Rouanet, Philippe Auzeloux, et al.. (2022). Phase I study of [131I] ICF01012, a targeted radionuclide therapy, in metastatic melanoma: MELRIV-1 protocol. BMC Cancer. 22(1). 417–417. 8 indexed citations
12.
Rouanet, Jacques, et al.. (2022). Gliptin-induced bullous pemphigoid: withdrawal of gliptin allows for faster control of the disease. European Journal of Dermatology. 32(3). 368–372. 1 indexed citations
13.
Quintana, Mercédès, Sophie Besse, Philippe Auzeloux, et al.. (2021). Efficacy of Targeted Radionuclide Therapy Using [131I]ICF01012 in 3D Pigmented BRAF- and NRAS-Mutant Melanoma Models and In Vivo NRAS-Mutant Melanoma. Cancers. 13(6). 1421–1421. 7 indexed citations
14.
Rouanet, Jacques, Mercédès Quintana, Philippe Auzeloux, F. Cachin, & Françoise Degoul. (2021). Benzamide derivative radiotracers targeting melanin for melanoma imaging and therapy: Preclinical/clinical development and combination with other treatments. Pharmacology & Therapeutics. 224. 107829–107829. 16 indexed citations
15.
Rouanet, Jacques, Anà Hennino, Philippe Auzeloux, et al.. (2020). Immune checkpoint inhibitors reverse tolerogenic mechanisms induced by melanoma targeted radionuclide therapy. Cancer Immunology Immunotherapy. 69(10). 2075–2088. 28 indexed citations
16.
Rouanet, Jacques, Sophie Besse, Eric Débiton, et al.. (2019). Determination of eumelanin and pheomelanin in melanomas using solid-phase extraction and high performance liquid chromatography–diode array detection (HPLC-DAD) analysis. Journal of Chromatography B. 1113. 60–68. 14 indexed citations
17.
Rouanet, Jacques, Claire Viallard, Sophie Besse, et al.. (2019). Targeted Radionuclide Therapy Decreases Melanoma Lung Invasion by Modifying Epithelial-Mesenchymal Transition-Like Mechanisms. Translational Oncology. 12(11). 1442–1452. 8 indexed citations
18.
Franck, F., et al.. (2018). A case of severe pityriasis rubra pilaris with a dramatic response to apremilast. European Journal of Dermatology. 28(1). 128–129. 9 indexed citations
19.
Talvas, Jérémie, Ghislain Garrait, Nicolas Gonçalves-Mendes, et al.. (2014). Immunonutrition stimulates immune functions and antioxidant defense capacities of leukocytes in radiochemotherapy-treated head & neck and esophageal cancer patients: A double-blind randomized clinical trial. Clinical Nutrition. 34(5). 810–817. 34 indexed citations
20.
Cazals, Yves, et al.. (1984). First results of chronic electrical stimulation with a round-window electrode in totally deaf patients. European Archives of Oto-Rhino-Laryngology. 239(3). 191–196. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Meng‐Fang Wu Breakdown of academic impact, for papers by M. I. Melhorn Breakdown of academic impact, for papers by Sara Cecco Breakdown of academic impact, for papers by Xinwei Yang Breakdown of academic impact, for papers by Yury Saenko Breakdown of academic impact, for papers by Lingling Liang Breakdown of academic impact, for papers by Young-Jae Kim Breakdown of academic impact, for papers by Lara Stepan Breakdown of academic impact, for papers by Ming‐Hao Dong
Rankless by CCL
2026